title: The management of primary mediastinal B-cell lymphoma with sclerosis.
authors.affiliation: Albert-Ludwigs University Medical Center, Department of Hematology/Oncology, Freiburg, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Brugger
authors.forename: R
authors.initials: R
authors.lastname: Engelhardt
authors.forename: R
authors.initials: R
authors.lastname: Mertelsmann
authors.forename: L
authors.initials: L
authors.lastname: Kanz
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016393:Lymphoma, B-Cell / Q000473:pathology / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology / Q000628:therapy*; D008479:Mediastinal Neoplasms / Q000473:pathology / Q000628:therapy*; D011241:Prednisone / Q000008:administration & dosage; D012598:Sclerosis; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone